Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.08 USD | -0.38% | +0.32% | -3.13% |
24/04 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
24/04 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- With a 2024 P/E ratio at 24.47 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.13% | 3.01B | B- | ||
0.00% | 1.97B | - | ||
+5.76% | 1.59B | C | ||
+53.74% | 643M | D+ | ||
-1.64% | 511M | - | ||
-35.42% | 368M | - | ||
-11.94% | 142M | - | ||
+1.92% | 67.85M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AMED Stock
- Ratings Amedisys, Inc.